Xeris Biopharma Holdings, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
XERS Nasdaq 2830 www.xerispharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Xeris Biopharma Holdings, Inc.

Xeris Biopharma Balances New Profitability With Recorlev Patent Battles - Mar 3rd, 2026 7:08 am
Xeris Biopharma Holdings Inc (XERS) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... - Mar 2nd, 2026 2:01 pm
Xeris Biopharma Holdings, Inc. Q4 2025 Earnings Call Summary - Mar 2nd, 2026 10:33 am
Xeris Biopharma (XERS) Q4 2025 Earnings Transcript - Mar 2nd, 2026 9:32 am
Xeris Biopharma Q4 Earnings Call Highlights - Mar 2nd, 2026 8:37 am
Xeris Biopharma (XERS) Reports Q4 Earnings: What Key Metrics Have to Say - Mar 2nd, 2026 7:30 am
Xeris Biopharma (XERS) Q4 Earnings and Revenues Surpass Estimates - Mar 2nd, 2026 6:06 am
Xeris Biopharma: Q4 Earnings Snapshot - Mar 2nd, 2026 5:13 am
Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance - Mar 2nd, 2026 5:00 am
A Look At Xeris Biopharma Holdings (XERS) Valuation As It Fights To Protect Recorlev Exclusivity - Mar 1st, 2026 11:11 am
Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit - Feb 26th, 2026 3:55 pm
BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates - Feb 26th, 2026 10:15 am
Unlocking Q4 Potential of Xeris Biopharma (XERS): Exploring Wall Street Estimates for Key Metrics - Feb 26th, 2026 7:15 am
TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI - Feb 26th, 2026 3:35 am
Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026 - Feb 17th, 2026 5:30 am
Is It Too Late To Consider Xeris Biopharma Holdings (XERS) After Its 133% One-Year Surge? - Jan 10th, 2026 7:10 pm
Assessing Xeris Biopharma Holdings (XERS) Valuation After Strong Recent Shareholder Returns - Jan 10th, 2026 12:08 pm
Why Xeris Biopharma Holdings (XERS) Is Up 7.9% After Raising 2025 Revenue Outlook and Adding Patents - Jan 10th, 2026 2:15 am
Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue - Jan 8th, 2026 5:00 am
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Jan 2nd, 2026 2:15 pm